Expanded Access to Provide Selitrectinib for the Treatment of Cancers With a NTRK Gene Fusion
Clinical trial NCT03206931 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT03206931
- Sponsor
- Bayer
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.